Exhibit 10.1 Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. RESEARCH COLLABORATION AND OPTION AGREEMENT by and between HYBRIDON, INC.Research Collaboration and Option Agreement • August 9th, 2005 • Hybridon Inc • Biological products, (no disgnostic substances) • New York
This Research Collaboration and Option Agreement (the "Agreement"), shall be effective as of June 8th, 2000 (the "Effective Date") between Emisphere -------------- Technologies, Inc., a Delaware corporation ("Emisphere"), and Eli Lilly and ---------...Research Collaboration and Option Agreement • October 25th, 2000 • Emisphere Technologies Inc • Pharmaceutical preparations • New York
Research Collaboration and Option Agreement (the "Agreement"), dated and effective as of March 8, 2000 (the "Effective Date") between Emisphere -------------- Technologies, Inc., 765 Old Saw Mill River Road, Tarrytown, NY 10591 a Delaware corporation...Research Collaboration and Option Agreement • June 13th, 2000 • Emisphere Technologies Inc • Pharmaceutical preparations • New York
EXHIBIT 10.1 PORTIONS OF THIS EXHIBIT HAVE BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. SUCH PORTIONS ARE DESIGNATED "[***]". RESEARCH COLLABORATION AND OPTION AGREEMENT -------------------------------------------Research Collaboration and Option Agreement • April 21st, 1997 • Emisphere Technologies Inc • Pharmaceutical preparations • New York
EXHIBIT 10.1 PORTIONS OF THIS EXHIBIT HAVE BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. SUCH PORTIONS ARE DESIGNATED "[***]". RESEARCH COLLABORATION AND OPTION AGREEMENT -------------------------------------------Research Collaboration and Option Agreement • March 17th, 1997 • Emisphere Technologies Inc • Pharmaceutical preparations • New York